Nutex helps regulatory science and biomedical research teams move faster, without cutting corners on the oversight their work requires.

September 29, 2026

GAITHERSBURG, Md., September 29, 2026. Cognizance Technologies today announced Nutex, an intelligent platform, engineered by Cognizance, an enterprise AI platform built to help regulatory science and biomedical research teams move faster without cutting corners on the oversight their work requires.

Regulatory science and biomedical research teams lose real time to hurdles that have nothing to do with the science itself: paperwork, disconnected systems, and approvals that stall a project instead of protecting it.

Much of that lost time is process, not science. Manual documentation, systems that do not talk to each other, and approvals that were never designed around how the work actually happens all push a result further from the people waiting on it. In regulatory science and biomedical research, that delay is rarely about the underlying work being hard. It is about everything built up around it.

Nutex is built to close that gap. It is not another AI tool added to the pile. It orchestrates AI tools, including agentic ones, inside a governed workflow: AIDE captures how a process should work as a structured specification, and ACE runs it, coordinating the right tools for each step while keeping a qualified person in control of the decisions that matter. Nutex runs on Amazon Web Services (AWS), where Cognizance holds AWS Partner Select Tier Services status.

AI becomes more useful when it is designed around the way people actually work, not when people are expected to redesign their work around the technology. We built Nutex to give teams a way to define the process first, bring AI into that process deliberately, and keep responsibility with the people who understand the work. That distinction is fundamental to how we think about enterprise AI, said Konstantin Trapaidze, Chief Technology Officer at Cognizance Technologies.

In practice, that means a regulatory science or biomedical research team starts with a specification instead of a blank page, and can trust that a workflow will pause for a qualified reviewer wherever judgment is still required, whether the process runs for an afternoon or several weeks. That is the shift Nutex is built around: not removing people from the process, but removing the friction around them.

To learn more about Nutex, visit nutex.ai.

About Cognizance Technologies

Cognizance Technologies, is a small fast-growing minority, disadvantaged, and woman-owned business. We offer a full range of Health Information Technology and systems engineering services to our clients in the public and private sectors. With proven, successful government subcontracting experience, we have enhanced our core competencies by creating client-focused, cost-effective information technology solutions.

About Nutex

Nutex is an enterprise AI, intelligent platform engineered by Cognizance, built for regulated, expert-driven industries, including biomedical research, regulatory science, and federal health IT. Rather than functioning as a single AI tool, Nutex orchestrates multiple AI tools, including agentic ones, inside a governed workflow, using AIDE to define how a process should work and ACE to run it with human oversight built in.